Page last updated: 2024-11-05

chlorbromuron

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chlorbromuron: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25912
CHEMBL ID1275654
CHEBI ID3608
SCHEMBL ID65119
MeSH IDM0062910

Synonyms (45)

Synonym
urea, n'-(4-bromo-3-chlorophenyl)-n-methoxy-n-methyl-
13360-45-7
chlorbromuron
NCGC00166178-01
einecs 236-411-9
caswell no. 173a
hsdb 1536
1-(3-chloro-4-bromophenyl)-3-methyl-3-methoxyurea
c-6313 ,
brn 2128736
epa pesticide chemical code 090701
ciba 6313
urea, 3-(4-bromo-3-chlorophenyl)-1-methoxy-1-methyl-
c 6313
3-(4-bromo-3-chlorophenyl)-1-methoxy-1-methylurea
chlorbromuron [bsi:iso]
n-(4-bromo-3-chlorophenyl)-n'-methoxy-n'-methylurea
bromex (herbicide)
chlorobromuron [iso-french]
n'-(4-bromo-3-chlorophenyl)-n-methoxy-n-methylurea
maloran
chlorobromuron
NCGC00166178-02
n'-(4-bromo-3-chlorophenyl)-n-methhoxy-n-methylurea
2x2dqc5ehg ,
unii-2x2dqc5ehg
CHEMBL1275654
chebi:3608 ,
NCGC00254697-01
tox21_300793
cas-13360-45-7
dtxsid6040290 ,
dtxcid4020290
chlorobromouron
chlorbromuron [hsdb]
chlorbromuron [iso]
SCHEMBL65119
NLYNUTMZTCLNOO-UHFFFAOYSA-N
n'-(4-bromo-3-chlorophenyl)-n-methoxy-n-methylurea #
1-(4-bromo-3-chlorophenyl)-3-methoxy-3-methylurea
3-(4-bromo-3-chloro-phenyl)-1-methoxy-1-methyl-urea
chlorobromouron, pestanal(r), analytical standard
chlorbromuron 100 microg/ml in acetonitrile
J-006412
Q22807251
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ureas
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency39.91490.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency19.33120.006038.004119,952.5996AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency64.86010.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency49.78750.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency54.48270.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency33.40010.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency48.55770.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency13.96150.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency7.13250.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency27.30600.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.33790.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743079; AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency61.64480.001019.414170.9645AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency24.27040.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency3.06380.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency64.75280.001628.015177.1139AID1224895
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency66.05580.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency27.30600.037617.082361.1927AID1259364; AID1259388
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency76.95880.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency76.95880.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (45.45)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.35 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]